JAK2 and Chronic Eosinophilic Leukemia, Not Otherwise Specified: To verify both leading PCM1-JAK2 targets SOCS2 and SOCS3, we measured their expression in a CEL patient with t(8;9)/PCM1-JAK2 [22].